237 related articles for article (PubMed ID: 10509664)
1. Intrafamilial variation of phenotype in Stargardt macular dystrophy-Fundus flavimaculatus.
Lois N; Holder GE; Fitzke FW; Plant C; Bird AC
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2668-75. PubMed ID: 10509664
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of Stargardt's disease and fundus flavimaculatus.
Armstrong JD; Meyer D; Xu S; Elfervig JL
Ophthalmology; 1998 Mar; 105(3):448-57; discussion 457-8. PubMed ID: 9499775
[TBL] [Abstract][Full Text] [Related]
3. Hypotrichosis with juvenile macular dystrophy: clinical and electrophysiological assessment of visual function.
Leibu R; Jermans A; Hatim G; Miller B; Sprecher E; Perlman I
Ophthalmology; 2006 May; 113(5):841-7.e3. PubMed ID: 16650681
[TBL] [Abstract][Full Text] [Related]
4. [Fundus autofluorescence imaging in patients with Stargardt dystrophy and fundus flavimaculatus].
Dolar-Szczasny J; Mackiewicz J; Biziorek B; Zagórski Z
Klin Oczna; 2007; 109(4-6):176-8. PubMed ID: 17725280
[TBL] [Abstract][Full Text] [Related]
5. Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.
Michaelides M; Wilkie SE; Jenkins S; Holder GE; Hunt DM; Moore AT; Webster AR
Ophthalmology; 2005 Aug; 112(8):1442-7. PubMed ID: 15953638
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus.
Lois N; Holder GE; Bunce C; Fitzke FW; Bird AC
Arch Ophthalmol; 2001 Mar; 119(3):359-69. PubMed ID: 11231769
[TBL] [Abstract][Full Text] [Related]
7. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular genetic analysis of best vitelliform macular dystrophy.
Boon CJ; Theelen T; Hoefsloot EH; van Schooneveld MJ; Keunen JE; Cremers FP; Klevering BJ; Hoyng CB
Retina; 2009 Jun; 29(6):835-47. PubMed ID: 19357557
[TBL] [Abstract][Full Text] [Related]
9. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.
Rotenstreich Y; Fishman GA; Anderson RJ
Ophthalmology; 2003 Jun; 110(6):1151-8. PubMed ID: 12799240
[TBL] [Abstract][Full Text] [Related]
10. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
[TBL] [Abstract][Full Text] [Related]
11. Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus.
Lois N; Halfyard AS; Bird AC; Holder GE; Fitzke FW
Am J Ophthalmol; 2004 Jul; 138(1):55-63. PubMed ID: 15234282
[TBL] [Abstract][Full Text] [Related]
12. Sorsby's fundus dystrophy: a case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography.
Lip PL; Good PA; Gibson JM
Eye (Lond); 1999; 13 ( Pt 1)():16-25. PubMed ID: 10396378
[TBL] [Abstract][Full Text] [Related]
13. A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
Khurana RN; Sun X; Pearson E; Yang Z; Harmon J; Goldberg MF; Zhang K
Ophthalmology; 2009 Oct; 116(10):1976-83. PubMed ID: 19616854
[TBL] [Abstract][Full Text] [Related]
14. Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation.
Gerth C; Andrassi-Darida M; Bock M; Preising MN; Weber BH; Lorenz B
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):628-38. PubMed ID: 12192456
[TBL] [Abstract][Full Text] [Related]
15. Course of visual decline in relation to the Best1 genotype in vitelliform macular dystrophy.
Booij JC; Boon CJ; van Schooneveld MJ; ten Brink JB; Bakker A; de Jong PT; Hoyng CB; Bergen AA; Klaver CC
Ophthalmology; 2010 Jul; 117(7):1415-22. PubMed ID: 20381869
[TBL] [Abstract][Full Text] [Related]
16. Intrafamilial clinical heterogeneity associated with a novel mutation of the retinal degeneration slow/peripherin gene.
Simonelli F; Testa F; Marini V; Interlandi E; Rossi S; Pognuz DR; Virgili G; Garrè C; Bandello F
Ophthalmic Res; 2007; 39(5):255-9. PubMed ID: 17851265
[TBL] [Abstract][Full Text] [Related]
17. Sorsby's fundus dystrophy.
Weisinger HS; Pesudovs K
Optometry; 2001 Jul; 72(7):435-40. PubMed ID: 11486938
[TBL] [Abstract][Full Text] [Related]
18. Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22.
Peters AL; Greenberg J
Retina; 1995; 15(6):480-5. PubMed ID: 8747441
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant macular atrophy at 6q14 excludes CORD7 and MCDR1/PBCRA loci.
Griesinger IB; Sieving PA; Ayyagari R
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):248-55. PubMed ID: 10634627
[TBL] [Abstract][Full Text] [Related]
20. Fundus autofluorescence in a case of occult macular dystrophy.
Rasquin F; Van Nechel C; Cordonnier M
Bull Soc Belge Ophtalmol; 2009; (313):9-12. PubMed ID: 20108567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
